The Referral to Hepatology Can be Improved Through an Electronic Medical Record (EMR)-Based Best Practice Alert (BPA) for an Appropriate Referral

Part of paid clinical trials in Kansas City, Kansas.

Sponsor
University of Kansas Medical Center
Study ID
NCT07580482
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Best Practice Alert — BEHAVIORAL
    To determine if rates of screening and referral to hepatology can be improved through an EMR-based BPA for an appropriate referral.
  • No Intervention — BEHAVIORAL
    The only intervention is the Best Practice Alert (BPA). Providers from three departments will be randomized to one of two groups: one that receives a BPA and one that does not. Thereafter, the study will observe patients who fit criteria for NASH referral, as defined by a diagnosis of T2DM and appropriate Fib4 score to determine if they have been referred to Hepatology for assessment.

Study Details

The purpose of this study is to promote the diagnosis and awareness of Non-Alcoholic Steatohepatitis (NASH) by linkage of care.

Key Dates

Start date
Jul 15, 2020
Status verified
May 2026
Primary completion
Jul 15, 2022
Completion
Jul 15, 2022

Study Design

Enrollment
30 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER

Arms

  • Experimental: Experimental Unit:
    Providers from internal medicine, family medicine and endocrinology clinics.
  • Other: Observation Unit:
    Patients from internal medicine, family medicine, and endocrinology clinics. Patients with an ICD 10 diagnosis of T2D E11.9. Patients have the most recent calculated FIB-4 Score of \>3.25.

Primary Outcome Measure

Determine if rates of referral to hepatology can be improved through EMR-based Best Practice Alert (BPA) for an appropriate referral. Name of the specific primary outcome measure [ Time Frame: 12 months ]

Locations (1)

FacilityCityStateZIPSite coordinators
University of Kansas Medical CenterKansas CityKansas66160-

Find similar trials in Kansas City, KS

By condition
Type 2 diabetes
By specialty
EndocrinologyMetabolic healthWeight loss
By research site
University of Kansas Medical Center· Kansas City, KS

Related Studies